phenol has been researched along with Glioblastoma in 1 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The non-invasive treatment of glioblastoma (GBM) is of great significance and can greatly reduce the complications of craniotomy." | 1.62 | A novel hypocrellin-based assembly for sonodynamic therapy against glioblastoma. ( Lee, CS; Liu, W; Wang, P; Wu, J; Zhang, C; Zhang, W; Zheng, X, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Wu, J | 1 |
| Liu, W | 1 |
| Zheng, X | 1 |
| Zhang, W | 1 |
| Lee, CS | 1 |
| Wang, P | 1 |
1 other study available for phenol and Glioblastoma
| Article | Year |
|---|---|
A novel hypocrellin-based assembly for sonodynamic therapy against glioblastoma.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Cell Proliferation; Drug Screening | 2021 |